Drug offers ‘wonderful’ breakthrough in treatment of asbestos-linked cancer

Medicine used alongside chemotherapy in trials quadrupled three-year survival rates for mesothelioma

You're viewing a single thread.

6 comments

1.6 month increased average survival. Spin it and slice the numbers however they want to, thats still pretty grim.
- It is grim, but the average does not tell the whole story. From what I understand, it extends the life of several patients for a long time, with 4x more patients surviving three years after diagnosis. The average is low because, just as with most cancer drugs, it only helps a percentage of the patients.

You've viewed 6 comments.